Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elaprase in MPS II Patients <6 Years Old
NCT02455622Phase 4Completed
- Sponsor
- Takeda
- Start
- Oct 2015
- Primary completion
- Jul 2025
- Modality
- Replacement Enzymes
- Countries
- 8
01
Overview
A Phase 4 trial of idursulfase in mucopolysaccharidosis type 2, sponsored by Takeda. Started Oct 2015; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on NCT02455622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455622.